ClinicalTrials.Veeva

Menu

Prevention Bundles for SSIs (PREBUSSI).

M

Maximos Frountzas

Status

Completed

Conditions

Surgical Site Infection

Treatments

Procedure: Prevention Bundles for SSIs

Study type

Observational

Funder types

Other

Identifiers

NCT05548764
PREBUSSI 2022

Details and patient eligibility

About

Surgical site infections (SSIs) are the most complication after a surgical operation and their incidence reaches 20% worldwide. SSIs have been associated to significant morbidity and mortality, high ICU admission rates, increased length of hospital stay, high readmission rates and raised cost. However, there is no registry for SSIs in Greece so far. In addition, it has been considered that almost half of SSIs could be prevented. Therefore, several prevention strategies have been suggested by international health organizations, such as WHO and NICE, that seem to be effective. The aim of the present study is to investigate the effect of 10 prevention bundles on the rate of SSIs, as well their consequences on several financial parameters of the Greek healthcare system.

Full description

  • 1st phase (2 months) → SSIs rate among abdominal surgical operations and reporting of patients' demographics (gender, age, comorbidities), type of surgery (upper GI, HPB, colorectal), surgical approach (open, laparoscopic), urgency classification, operation time, cost, pathogen cultures and antibiotic sensitivity test.

  • 2ο phase (10 months) → implementation of 10 prevention bundles:

    1. Antibiotic delivery 1-1.5 hours before surgical incision and repeat every 4 hours intraoperatively.
    2. Hair removal with electric hair clippers using single-use bladdes.
    3. Surgical scrub with Povidone Iodine solution 4% (Betadine Surgical Scrub)
    4. Skin preparation with chlorexidine alcohol-based antiseptic solution 2%.
    5. Intraoperative and postoperative (4-6 hours) normothermia (>36οC) using warmed forced-air blankets.
    6. Perioperative normoglycemia (Glu<200mg/dl) in diabetic patients.
    7. Single-use drapes and gowns.
    8. Surgical team glove changing by before skin incision closing.
    9. Single-layer surgical incision closure with triclosan plus antimicrobial-coated sutures.
    10. Wound irrigation (skin and subcutaneous fat) with Povidone Iodine solution (Betadine) after abdominal wall closure.
  • Implementation check of 10 prevention bundles preoperatively, intraoperatively and postoperatively.

  • Clinical assessment on POD 1, 3, 7 and 1 month postoperatively for SSI presence (according to WHO 2018 definition).

  • Reporting of patients' demographics (gender, age, comorbidities), type of surgery (upper GI, HPB, colorectal), surgical approach (open, laparoscopic), urgency classification, operation time, length of stay, cost, pathogen cultures and antibiotic sensitivity test.

Enrollment

200 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 18 years old
  2. Signed consent from patient or authorized representative
  3. Abdominal surgery
  4. Open or laparoscopic operations

Exclusion criteria

  1. Age < 18 years old
  2. No signed consent from patient or authorized representative
  3. Neck, thoracic, anal, lumbar operations
  4. No closure of abdominal wall or open abdomen

Trial design

200 participants in 2 patient groups

Prevention Bundles
Description:
Patients in which prevention bundles for SSIs have been implemented.
Treatment:
Procedure: Prevention Bundles for SSIs
No Prevention Bundles
Description:
Patients in which prevention bundles for SSIs have not been implemented.

Trial contacts and locations

1

Loading...

Central trial contact

Maximos Frountzas, MD MPA PhD; Konstantinos G Toutouzas, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems